FDA Inspection 1124670 — Corden Pharma S.p.A.

Corden Pharma S.p.A. — FEI 3002880938

The FDA completed an inspection of Corden Pharma S.p.A. on June 14, 2019 in Caponago. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 14, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Caponago (Italy)

Additional Details

Mutual Recognition Agreement (MRA)